Skip to main navigation
Skip to search
Skip to main content
Tampere University Research Portal Home
Help & FAQ
English
Suomi
Home
Profiles
Research outputs
Research units
Activities
Datasets and software
Research Infrastructures
Press/Media
Prizes
Search by expertise, name or affiliation
Gut Connection in IgA Nephropathy
Jussi Pohjonen
Internal and Respiratory medicine & Critical care, Skin & Allergy
SIST, Internal medicine
Research output
:
Book/Report
›
Doctoral thesis
›
Collection of Articles
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gut Connection in IgA Nephropathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Autoantibodies
3%
Autoimmunity
7%
Biological Marker
21%
Biopsy Technique
3%
Cell Damage
3%
Coeliac Disease
17%
Corticosteroid Therapy
3%
Crohn's Disease
7%
Diseases
7%
End Stage Renal Disease
7%
Faecal Calprotectin
3%
Fatty Acid Binding Protein 2
3%
Gastrointestinal Distress
39%
Glomerulonephritis
3%
Gut
100%
Immunoglobulin A Nephropathy
100%
Infection
3%
Inflammatory Bowel Disease
46%
Interstitial Nephritis
7%
Intestinal Permeability
7%
Intestine Injury
10%
Kidney Disorder
3%
Kidney Function
3%
Lipopolysaccharide Binding Protein
3%
Microhematuria
3%
Nephropathy
3%
Patient Experience
7%
Population
3%
Prevalence
42%
Protein Glutamine Gamma Glutamyltransferase 2
3%
Quality of Life
7%
Rating Scale
10%
Renal Biopsy
10%
Renal Failure
3%
Stomach Acid
7%
Ulcerative Colitis
3%
Volunteer
7%
Keyphrases
21st Century
3%
Autoantibody Detection
3%
Catchment Area
3%
Celiac Disease
10%
Celiac Disease Autoimmunity
3%
Cell Damage
3%
Clinical Indications
3%
Clinical Presentation
3%
Clinical Signs
3%
Cluster of Differentiation
3%
Coeliac Autoimmunity
7%
Corticosteroid Therapy
3%
Crohn's Colitis
3%
Crohn's Disease
3%
Dialysis Patients
3%
Dyspepsia
7%
End-stage Kidney Disease
7%
Enterocyte
3%
Fecal Calprotectin
3%
Female Patients
3%
Gastrointestinal Diseases
25%
Gastrointestinal Problems
3%
Gastrointestinal Symptom Rating Scale
10%
Gross Hematuria
3%
Gut-kidney Axis
3%
Health-related Quality of Life
7%
Healthy Controls
3%
Healthy Individuals
7%
Healthy People
17%
Histology
3%
I-FABP
3%
IgA Nephropathy (IgAN)
100%
Increased Intestinal Permeability
3%
Indirect Biomarker
10%
Inflammatory Bowel Disease
46%
Intestinal Injury
10%
Intestinal Permeability
3%
Intestine
10%
Kidney
7%
Kidney Biopsy
10%
Kidney Disease
7%
Kidney Failure
3%
Lipopolysaccharide-binding Protein
3%
Mucosal Infection
3%
Non-associated
3%
Patient Experience
7%
Patient-controlled
3%
Population Prevalence
3%
Preserved Renal Function
3%
Primary Glomerulonephritis
3%
Psychological General Well-Being
3%
Refractory Celiac Disease
3%
Serum Levels
28%
Symptom Level
3%
Tampere
10%
Targeting Antibodies
3%
Transglutaminase 2
3%
Tubulointerstitial Nephritis
7%
University Hospital
10%
Volunteer Patients
3%
Pharmacology, Toxicology and Pharmaceutical Science
Autoantibodies
3%
Biological Marker
21%
Calgranulin
3%
Coeliac Disease
17%
Crohn's Disease
7%
Diseases
7%
End Stage Renal Disease
7%
Enteropathy
3%
Fatty Acid Binding Protein 2
3%
Gastrointestinal Symptom
39%
Glomerulonephritis
3%
Hematuria
3%
Immunoglobulin A Nephropathy
100%
Infection
3%
Inflammatory Bowel Disease
46%
Interstitial Nephritis
7%
Intestinal Permeability
7%
Intestine Injury
10%
Kidney Disease
7%
Kidney Failure
3%
Lipopolysaccharide Binding Protein
3%
Normal Human
21%
Prevalence
42%
Protein Glutamine Gamma Glutamyltransferase 2
3%
Stomach Acid
7%
Ulcerative Colitis
3%
Immunology and Microbiology
Gut-kidney Axis
3%